SYNGENE — Syngene International Balance Sheet
0.000.00%
- IN₹301.01bn
- IN₹295.59bn
- IN₹34.89bn
Annual balance sheet for Syngene International, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10,199 | 10,659 | 12,817 | 13,561 | 10,767 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,278 | 5,857 | 6,324 | 6,592 | 5,580 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16,126 | 18,067 | 22,059 | 24,253 | 19,590 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 21,971 | 23,815 | 26,881 | 27,772 | 36,175 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 41,629 | 48,832 | 55,638 | 58,310 | 61,516 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15,392 | 11,330 | 12,289 | 11,882 | 11,442 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 19,871 | 20,618 | 22,662 | 22,130 | 18,938 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 21,758 | 28,214 | 32,976 | 36,180 | 42,578 |
Total Liabilities & Shareholders' Equity | 41,629 | 48,832 | 55,638 | 58,310 | 61,516 |
Total Common Shares Outstanding |